Navigation Links
Profil Institute Partners with Florida Hospital to Establish East Coast Center for Clinical Metabolic Research

SAN DIEGO and ORLANDO, Fla., June 8, 2012 /PRNewswire/ -- Profil® Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, and Florida Hospital, one of nation's largest clinical care providers, announced today a joint venture to establish a state-of-the-art early phase clinical services center for metabolic disease research, including diabetes, obesity and cardiometabolic diseases. The Profil Institute at Florida Hospital will initially be located at the new Florida Hospital-Sanford-Burnham Translational Research Institute (TRI) facility in Orlando and is expected to begin operations in late 2012.  The institute will join the TRI as part of Florida Hospital's Health Village development zone and will bring approximately 75 new jobs to the region over the next 5 years.

"Profil Institute fulfills an important need by providing the critical services of early phase clinical trials.  It is their sciencific expertise and disease-focused approach in metabolic diseases that make Profil Institute an ideal collaborative partner," said Dr. Steven R. Smith, a key opinion leader in obesity and metabolism research and Scientific Director at TRI.

"Florida Hospital and its Translational Research Institute are positioned to make incredible advancements in metabolic research as a marriage between one of the nation's largest clinical care providers and a leading academic institute," said Profil Institute CEO Dr. Marcus Hompesch. "Profil Institute is pleased to be a strategic partner with Florida Hospital in this powerful collaborative effort that is sure to result in positive therapeutic outcomes for diabetes, obesity and related diseases."

The joint venture combines Florida Hospital's patient network on the East Coast and TRI's translational research focus with Profil Institute's Center of Excellence reputation and capabilities in early phase clinical metabolic drug development.  Profil Institute at Florida Hospital will expand Profil Institute's capacity to now offer disease focused early phase clinical research services out of two locations, the company's core facility located in Chula Vista, California, and the newly established Profil Institute at Florida Hospital in Orlando.

Profil Institute's broader geographical reach and the institute's ability to cover the entire spectrum of metabolic early phase clinical research services from drug development planning to study protocol design and execution to report writing and peer-reviewed publications, further positions Profil Institute as a strategic alliance partner for their bio-pharmaceutical clients. Profil Institute's capabilities and Center of Excellence approach will continue to produce meaningful early phase data to increase the efficiency of later phase clinical trials and will continue to play a significant role in helping to qualify or dis-qualify metabolic drug leads as early as possible in the clinical development process.

About Florida Hospital

With eight hospitals and 21 urgent care locations, Florida Hospital is one of the largest not-for-profit hospitals in the country, caring for more than a million patient visits per year – more than any other hospital in the country, according to the American Hospital Association.  The more than 2,000-bed system, has been recognized by U.S. News & World Report as one of the best hospitals in the country.

With advanced research and industry partnerships, Florida Hospital seeks to extend and improve the quality of lives through the translation of fundamental scientific discoveries to the diagnosis and treatment of human disease. For more information, please visit

About TRI

The Florida Hospital-Sanford-Burnham Translational Research Institute for Metabolism and Diabetes (TRI) is the product of an innovative affiliation between Florida Hospital and Sanford-Burnham Medical Research Institute. By linking one of the largest not-for-profit hospitals in the country with a nationally renowned basic science leader, the TRI bridges the gap between the research bench and the patient's bedside. The mission of the TRI is to extend and improve the quality of lives through the translation of fundamental scientific discoveries to the diagnosis and treatment of human disease. For additional information, please visit

About Profil® Institute for Clinical Research, Inc.

Profil Institute is world-renowned as a Center of Excellence for diabetes and obesity early phase clinical research.  The company's advances in early phase drug research and its specific focus on diabetes, obesity and cardiometabolic diseases as it relates to the diabetic patient population have led Profil Institute to be the most highly regarded clinical research institute for early phase diabetes drug trials. 

Profil Institute has been involved with every clinically promising drug class and device development in diabetes and in more than 175 clinical studies since the company's inception in 2004. Contributing to Profil Institute's success is that the company is recognized as the leader in automated glucose clamps, considered the "Gold Standard" for the evaluation of anti-diabetic drugs and devices.  The company's key scientists hail from academic centers including the WHO Collaborating Center of Diabetes at the Heinrich-Heine University of Dusseldorf, Columbia University, University of Michigan and Harvard University. For more information visit

SOURCE Profil Institute for Clinical Research, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
2. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
3. Elekta and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Sign Strategic Alliance to Further Cancer Research
4. Scripps Research Institutes Richard A. Lerner Wins Prince of Asturias Award for Scientific and Technical Research
5. The Illinois Back Institute Helps Patient Beat Debilitating Back Pain
6. The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease
7. The Rogosin Institute and Hebrew Home Collaborate to Provide New Dialysis Service for Residents and Patients
8. Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis
9. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
10. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
11. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
Post Your Comments:
(Date:11/25/2015)... 26, 2015  The total global healthcare industry is expected ... Latin America has the highest projected ... Japan ), is second with growth projected ... face increased healthcare expenditure. In 2013-2014, total government funded healthcare ... in 2008-2009 to 41.2% in 2013-2014. In real terms, out ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma ... planned investment of at least $15.8  Million to ... Wilmington, NC . The expansion will ... to meet the growing demands of the pharmaceutical ... site expansion will provide up to 40,000 ...
(Date:11/25/2015)... AVIV, Israel , November 25, 2015 ... (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company ... simultaneous treatment of various clinical conditions, today announced the ... 3,158,900 American Depository Shares ( ADSs ), each representing ... purchase up to 3,158,900 ADSs. The ADSs and warrants ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... Dr. Thomas Dunlap and Dr. Patrick Coleman ... with Emergency Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , ... in similar ways and require time-critical intervention to avoid large area heart damage and ...
(Date:11/27/2015)... ... 27, 2015 , ... Indosoft Inc., developer and distributor of ... 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making ... with a version of Asterisk that will receive not only security fixes, but ...
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, they ... to buy during the Black Friday and Cyber Monday massage chair sales ... the Internet high and low to find the best massage chair deals, they can ...
(Date:11/26/2015)... ... November 26, 2015 , ... Somu Sivaramakrishnan announced today that ... Somu now offers travelers, value and care based Travel Services, including exclusive pricing ... well as, cabin upgrades and special amenities such as, shore excursions, discounted fares, ...
(Date:11/26/2015)... Omaha, NE (PRWEB) , ... November 26, 2015 , ... ... careers searched by healthcare professionals and offered by healthcare staffing agency Aureus Medical ... top during the month of October 2015 among those searching for healthcare jobs through ...
Breaking Medicine News(10 mins):